Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain zaps + robot hands: new combo therapy aims to restore stroke arm function

NCT ID NCT07054424

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining a non-invasive brain stimulation technique (rTMS) with machine-assisted hand exercises can help stroke survivors regain arm and hand movement. Researchers will enroll 54 adults aged 40-80 who had a first stroke within the past year. Participants will receive the combined therapy and be assessed before, right after, and during follow-up to see if their motor skills improve.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 54 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 40-80 years; 2. First-onset stroke patients; 3. Patients diagnosed with cerebral infarction or hemorrhage through CT or MRI; 4. Signed informed consent form by the patient and their family; 5. Stable physiological parameters; 6. Stroke occurred within the last 12 months; 7. Patients with unilateral hand function impairment caused by the stroke; 8. Upper limb muscle tone (Modified Ashworth Scale, MAS) less than 3 points; 9. Able to follow two-step commands. Exclusion Criteria: 1. A history of epilepsy or family history of epilepsy; 2. Presence of suicidal tendencies; 3. Currently using medications that lower the seizure threshold; 4. Pregnant or planning to become pregnant; 5. Co-existing neurological diseases (such as multiple sclerosis, other neurodegenerative diseases, meningitis, brain abscess, or meningioma); 6. Subjects with uncontrollable migraines caused by elevated intracranial pressure; 7. Subjects taking antidepressants who cannot discontinue the medication; 8. Subjects with sleep disorders during rTMS treatment; 9. Subjects with cerebellar stroke or brainstem stroke; 10. Cerebral ischemic disorders resulting from traumatic brain injury; 11. Transient ischemic attacks (TIAs); 12. History of bleeding tendency and other conditions affecting upper limb function, such as myasthenia gravis, systemic immune neuropathy, severe epilepsy, endocrine system disorders, wearers of external or internal cardiac pacemakers, individuals with metallic implants or orthopedic devices; 13. Co-existing severe heart, liver, kidney dysfunction, or other serious physical illnesses; 14. Subjects with impaired consciousness who cannot cooperate with examinations or treatments, such as those with mental disorders, or those with intellectual or cognitive impairments, severe dementia; 15. Presence of implanted electronic devices in the body; 16. Co-existing severe liver, kidney, or hematological disorders; 17. Special vulnerable populations; 18. Skin disease (e.g., pressure ulcers, trauma, cellulitis, etc.).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bimanual therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan

    RECRUITING

    Taoyuan, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.